Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 3 |
2012 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Apoptosis in targeted therapy responses: the role of BIM.
Adv Pharmacol. 2012;65:519-42. doi: 10.1016/B978-0-12-397927-8.00016-6.
Adv Pharmacol. 2012.
PMID: 22959036
Review.
Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors.
Qi J, McTigue MA, Rogers A, Lifshits E, Christensen JG, Jänne PA, Engelman JA.
Qi J, et al.
Cancer Res. 2011 Feb 1;71(3):1081-91. doi: 10.1158/0008-5472.CAN-10-1623. Epub 2011 Jan 25.
Cancer Res. 2011.
PMID: 21266357
Free PMC article.
Item in Clipboard
Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor.
Ercan D, Zejnullahu K, Yonesaka K, Xiao Y, Capelletti M, Rogers A, Lifshits E, Brown A, Lee C, Christensen JG, Kwiatkowski DJ, Engelman JA, Jänne PA.
Ercan D, et al.
Oncogene. 2010 Apr 22;29(16):2346-56. doi: 10.1038/onc.2009.526. Epub 2010 Feb 1.
Oncogene. 2010.
PMID: 20118985
Free PMC article.
Item in Clipboard
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.
Faber AC, Corcoran RB, Ebi H, Sequist LV, Waltman BA, Chung E, Incio J, Digumarthy SR, Pollack SF, Song Y, Muzikansky A, Lifshits E, Roberge S, Coffman EJ, Benes CH, Gómez HL, Baselga J, Arteaga CL, Rivera MN, Dias-Santagata D, Jain RK, Engelman JA.
Faber AC, et al.
Cancer Discov. 2011 Sep;1(4):352-65. doi: 10.1158/2159-8290.CD-11-0106. Epub 2011 Jul 22.
Cancer Discov. 2011.
PMID: 22145099
Free PMC article.
Item in Clipboard
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation.
Corcoran RB, Dias-Santagata D, Bergethon K, Iafrate AJ, Settleman J, Engelman JA.
Corcoran RB, et al.
Sci Signal. 2010 Nov 23;3(149):ra84. doi: 10.1126/scisignal.2001148.
Sci Signal. 2010.
PMID: 21098728
Free PMC article.
Item in Clipboard
Using tandem mass spectrometry in targeted mode to identify activators of class IA PI3K in cancer.
Yang X, Turke AB, Qi J, Song Y, Rexer BN, Miller TW, Jänne PA, Arteaga CL, Cantley LC, Engelman JA, Asara JM.
Yang X, et al.
Cancer Res. 2011 Sep 15;71(18):5965-75. doi: 10.1158/0008-5472.CAN-11-0445. Epub 2011 Jul 20.
Cancer Res. 2011.
PMID: 21775521
Free PMC article.
Item in Clipboard
Cite
Cite